Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

S&P Futures Tick Higher Ahead of FOMC Meeting, U.S. JOLTs Report and Microsoft Earnings in Focus

September S&P 500 E-Mini futures (ESU24) are trending up +0.17% this morning as market participants braced for the start of the Federal Reserve’s two-day policy meeting while also awaiting the latest reading on U.S. job openings as well as an earnings report from tech giant Microsoft.

1 High-Yield Dividend Stock to Buy and Hold

1 High-Yield Dividend Stock to Buy and Hold

Pfizer's stock shows signs of a potential rebound, buoyed by recent pipeline successes in hemophilia and obesity treatments, an attractive 5% dividend yield, and a rock-bottom valuation. This makes it an appealing dividend stock for value and income investors as the drug giant prepares to report earnings.

Option Volatility And Earnings Report For July 29 – August 2

Option Volatility And Earnings Report For July 29 – August 2

This week we have Apple, Advanced Micro Devices, Amazon, Pfizer, Coinbase, Meta Platforms, Intel, Exxon Mobil, Boeing, PayPal, Starbucks, McDonald’s and Chevron all set to report.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.

The Conversation

Ceos Condemn Political Violence After Trump Shooting

170 major CEOs unite to denounce political violence after Trump shooting, emphasizing peace and unity.

Here's What to Expect From Pfizer’s Next Earnings Report

As Pfizer gears up to release its second-quarter earnings this month, analysts project a double-digit bottom-line dip.

1 Big Pharma Dividend Stock to Snag While It's Still Cheap

Pfizer's stock presents a compelling investment opportunity, trading at an attractive valuation with a high dividend yield, as the company makes promising progress on its oral obesity drug, danuglipron, in a market dominated by injectable treatments.

inkl

Read news from The Economist, FT, and more,
with one subscription

Pfizer to move daily weight-loss pill to clinical trials

Firm says drug Danuglipron has shown ‘encouraging’ signs in early studies

Evening Standard

3 Value Stocks to Buy and Hold for Passive Income

3 Value Stocks to Buy and Hold for Passive Income

Amid market volatility, three value stocks - American International Group (AIG), Pfizer (PFE), and Schlumberger (SLB) - emerge as potential long-term investments for passive income, offering attractive valuations, solid dividends, and growth prospects for investors.

Vaccine panel more strongly endorses RSV shots for oldest Americans

Vaccine panel more strongly endorses RSV shots for oldest Americans

Federal advisers are making a stronger endorsement for RSV vaccinations for people 75 and older

The Independent UK

The Future of Weight-Loss Drugs for Investors

The Future of Weight-Loss Drugs for Investors

Weight-loss drugs’ impact could reach far beyond their target user, potentially creating headwinds for shares of snack makers and packaged-food firms, as well as medical device makers that specialize in knee replacements, insulin pumps and sleep apnea machines.

EU Chief's Texts For Covid Vaccines Under Court Scrutiny

EU Chief's Texts For Covid Vaccines Under Court Scrutiny

A Belgian court on Friday heard a lawsuit accusing European Commission chief Ursula von der Leyen of secretly negotiating Covid vaccine purchases via text message and arguing she should be barred from a second term.

International Business Times

3 Ultra High-Yield Dividend Stocks to Pounce On at Every Dip

3 Ultra High-Yield Dividend Stocks to Pounce On at Every Dip

These dividend stocks have consistently paid dividends with yields over 6%.

New RSV shots tied to rare nervous system disorder — should you worry?

New RSV shots tied to rare nervous system disorder — should you worry?

There's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But health officials still recommend that this population get the shots, in consultation with their doctors.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Healthcare Stocks With The Highest Yields As of June 2024

Looking for yield? Here's 3 healthcare stocks with the highest yields today.

The Independent UK

Combined Covid and flu vaccine could be approved for use on NHS by next year

New vaccine could cut need for separate Covid and flu jabs

The Independent UK

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

Government advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall

Should You Buy This S&P 500 Stock with a Dividend Yield of Nearly 6%?

With a dividend yield of nearly 6%, pharma giant Pfizer is among the highest-yielding S&P 500 stocks. While the stock's price action has been disappointing like most other high-dividend stocks, it looks worth a bet given the tepid valuations.

Get all your
news in one place.

100's of premium titles.
One news app.

Only 49 companies have been on the Fortune 500 for all 70 years. Here are their secrets to staying in power

Prolonged success boils down to a few subtle factors—but surprisingly, they don't include strategy, structure, technology, or even culture.

Bird flu vaccines face a problem: eggs

Fertilized hen eggs are still the main ingredient in making vaccines that may protect us against H5N1

The Independent UK

Scientists are testing mRNA vaccines to protect cows and people against bird flu

The bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA vaccines — akin to the shots deployed during the COVID-19 pandemic

International Business Times

Strong Trial Results For Pfizer Lung Cancer Drug

A Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung cancer, results published Friday showed.

Guillain-Barre Syndrome 'More Common Than Expected' In RSV Vaccinated Older Adults: CDC

While the U.S. Food and Drug Administration (FDA) and the officials from the CDC continue to investigate the risks, the current recommendation is to continue the vaccine as "the estimated benefits of RSV vaccination continued to outweigh potential risks."

CDC Reports Rare Nervous System Disorder In RSV Vaccine

CDC reports increased Guillain-Barre syndrome cases in older adults post-RSV vaccination, emphasizing benefits outweigh risks.

The Independent UK

Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates

Reports of a rare nervous system disorder are “more common than expected” in older U.S. adults who got the new RSV vaccines

1 … 16 17 18 19

People

204,817 stories

Ursula von der Leyen

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

the Federal Reserve

European Commission

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

401,920 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play